Taken together, our findings from the in vitro and in vivo assays not only highlight the oncogenic role of SRSF3 during oral carcinogenesis, but also strongly attest to the tumor-suppressive role of miR-6741-3p in OSCC, in part, by targeting SRSF3. This evidence concerns the gene SRSF3 and neoplasm.